Drug Profile
Research programme: abuse-resistant opioid analgesics - Neura Therapeutik
Alternative Names: NL-001; NL-002Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Neura Therapeutik
- Class Opioid analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pain in USA
- 18 Apr 2013 Early research in Pain in USA (unspecified route)